Alcon Secures FDA Approval for TRYPTYR (Acoltremon Ophthalmic Solution) 0.003% for Dry Eye Disease
TRYPTYR, the first TRPM8-targeting eye drop, improves tear production from Day 1 in dry eye patients. Alcon (Geneva, Switzerland) has…
FDA Clears Immunoglobulin Eye Drops for Phase II Dry Eye Trial
Biologic therapy enters clinical study to assess broad anti-inflammatory potential The U.S. FDA has granted IND clearance for a new…
latest posts
![[Internal] Stuart Pharma Clinical Trial Thumbnail 3](https://cookiemagazine.org/wp-content/uploads/sites/6/2025/01/Internal-Stuart-Pharma-Clinical-Trial-Thumbnail-3-579x326.png)
